On October 24, Oscar Health, Inc. fell 5.47% in Regular Trading, trading near $31.47 per share, with turnover of $53.65 million.

The clearest catalyst was a fresh sell-side call: UBS downgraded the stock to Neutral and set a $27 price target, which pressured risk appetite toward the shares.

Background context shows Oscar Health, Inc. recently announced expansion into South Carolina and launched RetireEase, a plan aimed at helping early retirees transition to Medicare, expanding its operating footprint to 21 states. Even so, more recent analyst commentary has turned more cautious ahead of the November 5 earnings release, with UBS previously noting that updated guidance already reflects favorable utilization trends and that third-quarter upside may be less certain.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)